About
Gene Therapy
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyBiotech
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
10
As Collaborator
0
Total Enrollment
1,254
By Phase
PHASE3: 2PHASE2: 1PHASE1/PHASE2: 5PHASE1: 1
By Status
RECRUITING: 5ACTIVE_NOT_RECRUITING: 4TERMINATED: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Today
Hover over trial bars to see details
Recent Trials
NCT07064759Lead Sponsor
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
PHASE3Recruiting
400 participants
Started: Jul 22, 2025 · Completed: Feb 28, 2029
NCT06864988Lead Sponsor
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
PHASE3Recruiting
400 participants
Started: Mar 3, 2025 · Completed: Jun 30, 2028
NCT05930561Lead Sponsor
4D-150 in Patients With Diabetic Macular Edema
PHASE2Active, not recruiting
72 participants
Started: Aug 9, 2023 · Completed: Feb 28, 2029
NCT05629559Lead Sponsor
4D-310 in Adults With Fabry Disease and Cardiac Involvement
PHASE1/PHASE2Recruiting
18 participants
Started: Oct 16, 2022 · Completed: Jun 30, 2030
NCT05248230Lead Sponsor
4D-710 in Adult Patients With Cystic Fibrosis
PHASE1/PHASE2Recruiting
40 participants
Started: Mar 29, 2022 · Completed: Jan 31, 2030
Locations (1)
Headquarters
Emeryville, CA, United States
Map
Loading map...